Moderna, an American biotech company, expects to start their largest study yet of its Covid-19 vaccine candidate on July 27, according to details released Tuesday on a government database that tracks clinical trials conducted around the world.

Here is how the vaccine trial will work:

  • For the phase three study, researchers plan to enroll 30,000 adult participants, including people whose locations or circumstances put them at high-risk of infection.
  • One group will be injected with 100 micrograms of the vaccine on day one and again on day 29. A second group will be injected with two doses of a placebo for comparison.
  • Fourteen days after the participants get their second dose, the researchers will be looking at whether they develop Covid-19.
  • The participants will be followed for two years after receiving their second dose.

The study will be conducted at 87 locations across the United States.

Remember: Moderna’s vaccine candidate is one of 23 in clinical trials around the world, according to the World Health Organization.

Moderna’s Covid-19 vaccine candidate is expected to be the first in the United States to begin phase three trials.

Source : CNN News


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.